Fate Therapeutics
FATE
#7766
Rank
S$0.31 B
Marketcap
$2.79
Share price
-6.76%
Change (1 day)
-15.02%
Change (1 year)

EPS for Fate Therapeutics (FATE)

EPS in 2023 (TTM): -$2.99

According to Fate Therapeutics 's latest financial reports the company's current EPS (TTM) is -$2.92. In 2022 the company made an earnings per share (EPS) of -$3.92 a decrease over its 2021 EPS that were of -$3.00.

EPS history for Fate Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.99-23.56%
2022-$3.9230.49%
2021-$3.007.21%
2020-$2.8045.45%
2019-$1.9219.17%
2018-$1.6117.65%
2017-$1.37-3.77%
2016-$1.43-12.4%
2015-$1.63-3.97%
2014-$1.70-2.09%
2013-$1.73

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$10.54 260.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.47-355.76%๐Ÿ‡บ๐Ÿ‡ธ USA
-$11.64 298.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.17 42.86%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.64-190.32%๐Ÿ‡บ๐Ÿ‡ธ USA